The size of India’s insulin market was an estimated Rs 4,404 crore in April this year, with Indian players making steady ...

The Pharma world is seeing a big opportunity in GLP-1s – the new innovative fast emerging drugs for diabetes & obesity. Kiran ...

President Trump’s executive order aims to bring down drug prices while optimizing IP protections, and Congress should pass ...